Cargando…
Sickle Cell Disease Patients Mount Adequate Humoral but Reduced Cellular Responses to COVID-19 Vaccination
Autores principales: | Pothast, Cilia R., Hofsink, Quincy, Haggenburg, Sabine, Bhoekhan, Michel, Haverkate, Nienke J.E., Dijkland, Romy C., van Dijk, Kayleigh, Falkenburg, Frederik J.H., Broers, Annoek E.C., van Doesum, Jaap, van Binnendijk, Robert S., den Hartog, Gerco, Burger, Judith A., Bouhuijs, Joey H., Lissenberg-Witte, Birgit I., Smits, Gaby P., Wouters, Dorine, van Leeuwen, Ester M.M., Bontkes, Hetty J., Kootstra, Neeltje A., Zweegman, Sonja, Kater, Arnon P., Groen, Kaz, van Meerten, Tom, Mutsaers, Pim G.N.J., Beaumont, Tim, van Gils, Marit J., Goorhuis, Abraham, Hazenberg, Mette D., Nijhof, Inger S., Heemskerk, Mirjam H.M., Rutten, Caroline E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The American Society of Hematology. Published by Elsevier Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9665207/ http://dx.doi.org/10.1182/blood-2022-169164 |
Ejemplares similares
-
For Better or for Worse: COVID-19 Vaccination during or Early after (Immuno-) Chemotherapy or Hematopoietic Progenitor Cell Transplantation
por: Haggenburg, Sabine, et al.
Publicado: (2021) -
P1536: SARS-COV-2 INFECTIONS IN PATIENTS WITH HAEMATOLOGIC MALIGNANCIES: EFFECT OF VACCINATION AND THE DEVELOPMENT OF HYBRID IMMUNITY
por: Haggenburg, Sabine, et al.
Publicado: (2023) -
Fourth mRNA COVID-19 vaccination in immunocompromised patients with haematological malignancies (COBRA KAI): a cohort study
por: Hofsink, Quincy, et al.
Publicado: (2023) -
Quantitative analysis of mRNA-1273 COVID-19 vaccination response in immunocompromised adult hematology patients
por: Haggenburg, Sabine, et al.
Publicado: (2022) -
SARS-CoV-2 vaccine-induced humoral and cellular immunity in patients with hematologic malignancies
por: Haggenburg, Sabine, et al.
Publicado: (2022)